Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 04/04/2024
|
IQVIA (IQV) Appreciates 24% in a Year: Here's What to Know
- IQVIA's (IQV) combined offerings of research and development and commercial services are helping it to develop trusted relationships.
- 04/02/2024
|
IQVIA (IQV) Up 5.3% Since Last Earnings Report: Can It Continue?
- IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
- 03/15/2024
|
IQVIA (IQV) Gains From Global IT Framework, Liquidity Low
- IQVIA's (IQV) revenue growth is primarily driven by global IT infrastructure and market size amid increasing operating expenses and low liquidity.
- 03/13/2024
|
IQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global Healthcare Conference on March 13, 2024
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays 26th Annual Global Healthcare Conference in Miami on Wednesday, March 13, 2024 at 9:30 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day. About IQVIA IQVI.
- 03/06/2024
|
IQVIA Holdings, Inc. (IQV) Q4 2023 Earnings Call Transcript
- IQVIA Holdings, Inc. (IQV) Q4 2023 Earnings Call Transcript
- 02/14/2024
|
IQVIA Holdings (IQV) Q4 Earnings & Revenues Beat Estimates
- IQVIA Holdings' (IQV) revenues increase year over year in fourth-quarter 2023.
- 02/14/2024
|
IQVIA Holdings (IQV) Surpasses Q4 Earnings and Revenue Estimates
- IQVIA Holdings (IQV) came out with quarterly earnings of $2.84 per share, beating the Zacks Consensus Estimate of $2.82 per share. This compares to earnings of $2.78 per share a year ago.
- 02/14/2024
|
IQVIA (IQV) to Report Q4 Earnings: What's in the Offing?
- IQVIA's (IQV) revenues are likely to increase year over year on the back of improving segmental performance.
- 02/09/2024
|
Stay Ahead of the Game With IQVIA (IQV) Q4 Earnings: Wall Street's Insights on Key Metrics
- Evaluate the expected performance of IQVIA (IQV) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 02/09/2024
|
IQV or IDXX: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Instruments sector have probably already heard of IQVIA Holdings (IQV) and Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?
- 01/31/2024
|
4 GARP Stocks to Scoop up for Maximum Returns
- Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. NRG, DRI, ALSN and IQV are some stocks that hold promise.
- 01/31/2024
|
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names
- The great advances and improvements in the treatment of diseases and the effectiveness of these medicines are undoubtedly due to technological progress and how biotech companies take advantage of it for their growth and development. Without the work of these companies, we would still be using very old and ineffective medicines.
- 01/10/2024
|
IQVIA (IQV) Climbs 17% in 3 Months: Here's What to Know
- IQVIA (IQV) benefits from revenue growth and disciplined cost management.
- 01/03/2024
|
3 Charts For Investors to Watch Tuesday: IQVIA Holdings, BGC Group, WGMI ETF
- Here's our daily look at three charts linked to recent news-driven price moves, with key technical levels to watch.
- 01/02/2024
|
Seven tech stocks that can broaden your exposure beyond the “Magnificent Seven”
- During the bull market of 2023, the “Magnificent Seven” stocks have dominated financial media coverage, and rightly so. There is no question that this group of companies has been performing very well in their core businesses and analysts expect the good times to continue.
- 12/20/2023
|
IQVIA (IQV) Stock Gains 8% in a Month: Here's What to Know
- IQVIA (IQV) aims at market expansion through innovation and service improvements.
- 12/07/2023
|
Why Is IQVIA (IQV) Up 12.4% Since Last Earnings Report?
- IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
- 12/01/2023
|
IQVIA: I Would Stay Away Until Debt Issues Are Resolved
- IQVIA is a global provider of contract research services and data analytics for the healthcare industry. The company helps clients drive healthcare forward by providing insights and solutions to improve. The Net Debt/EBITDA ratio is 4.6x, moreover, 55% of its debt is at a floating rate, which is very worrying in an environment with high rates. Although the company doesn't seem particularly expensive at its current valuation, I would demand a greater margin of safety until debt concerns are resolved.
- 11/12/2023
|
IQVIA Holdings (IQV) Q3 Earnings Surpass Estimates
- IQVIA Holdings (IQV) came out with quarterly earnings of $2.49 per share, beating the Zacks Consensus Estimate of $2.46 per share. This compares to earnings of $2.48 per share a year ago.
- 11/01/2023
|
IQVIA (IQV) to Report Q3 Earnings: What's in the Offing?
- IQVIA's (IQV) revenues are likely to increase year over year on the back of improving segmental performance.
- 10/26/2023
|
4 Medical Product Stocks Set to Outpace Q3 Earnings Estimates
- Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EW, PODD, DXCM and IQV are poised ahead of their earnings release.
- 10/19/2023
|
IQVIA to Announce Third-Quarter 2023 Results on November 1, 2023
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2023 financial results before the market opens on Wednesday, November 1, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the presentati.
- 10/09/2023
|
IQVIA (IQV) and argenx Partner to Advance Autoimmune Care
- IQVIA (IQV) and argenx expand collaboration to advance rare autoimmune treatments through innovative pharmacovigilance.
- 10/05/2023
|
Court strikes down federal rule that sharply increased prescription costs for many patients
- A federal court on Friday struck down a rule that sharply increased out-of-pocket prescription costs for many patients with complex conditions.
- 10/02/2023
|
Here's Why Investors Should Retain IQVIA (IQV) Stock Now
- An addressable market size and strong healthcare-specific global IT infrastructure boost IQVIA (IQV).
- 09/08/2023
|
IQVIA CEO Ari Bousbib to Speak at Morgan Stanley Annual Global Healthcare Conference on September 12, 2023
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Morgan Stanley Annual Global Healthcare Conference in New York City on Tuesday, September 12, 2023 at 11:30 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day. About IQVIA IQVIA (NYS.
- 09/01/2023
|
IQVIA (IQV) Up 2.5% Since Last Earnings Report: Can It Continue?
- IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
- 08/31/2023
|
3 Biotech Stocks That Wall Street Analysts Can't Get Enough Of
- This year has not been kind to biotech stocks, as the sector's most popular ETF, the iShares Biotechnology ETF (NASDAQ: IBB ), has fallen about 3% so far in 2023. Investors are probably worried about the impact of higher interest rates and potential reforms by Washington, DC on the sector.
- 08/30/2023
|
IQVIA (IQV) Stock Improves 8% in Three Months: Here's How
- IQVIA (IQV) aims at market expansion through innovation and service improvements.
- 08/25/2023
|
IQVIA Holdings' (IQV) Q2 Earnings Beat Estimates, Decline Y/Y
- IQVIA Holdings (IQV) second-quarter 2023 revenues improve year over year.
- 08/01/2023
|
IQVIA (IQV) Reports Q2 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for IQVIA (IQV) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 08/01/2023
|
IQVIA Holdings (IQV) Surpasses Q2 Earnings and Revenue Estimates
- IQVIA Holdings (IQV) came out with quarterly earnings of $2.43 per share, beating the Zacks Consensus Estimate of $2.37 per share. This compares to earnings of $2.44 per share a year ago.
- 08/01/2023
|
Analysts Estimate IQVIA Holdings (IQV) to Report a Decline in Earnings: What to Look Out for
- IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/25/2023
|
3 Stocks to Watch From a Promising Technology Services Industry
- The Zacks Technology Services industry seeks to benefit from the increased dependency on technology, digitization and the growing adoption of the multi-cloud model. TT, IQV and APTV are well poised to witness a demand surge.
- 07/19/2023
|
IQVIA (IQV) Stock Gains 10% in Three Months: Here's How
- IQVIA (IQV) aims at market expansion through innovation and service improvements.
- 07/11/2023
|
IQVIA to Announce Second-Quarter 2023 Results on August 1, 2023
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2023 financial results before the market opens on Tuesday, August 1, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the presentation.
- 07/06/2023
|
Stanley Druckenmiller is Bullish on AI, these are His Top 3 Stock Picks
- Famed investor, Stanley Druckenmiller hasn't been shy about how bearish he is on the market, stating that he still believes there will be a hard landing sometime in the next year. However, he notes that “AI could be as transformative as the internet,” and that AI companies could have very strong earnings even in the face of an economic downturn.
- 06/12/2023
|
Why You Should Retain IQVIA Holdings (IQV) Stock for Now
- IQVIA Holdings' (IQV) enormous treasure trove of information is a distinguishing asset and also perhaps a big barrier to entry for competitors.
- 06/07/2023
|
IQVIA's (IQV) Extensive Database Blocks New Entrants
- A strong database of patient records and a huge market are tailwinds for IQVIA's (IQV) success.
- 05/23/2023
|
IQVIA Holdings: A Possible Beat And Raise Scenario In The Works
- Despite some concerns about TAS performance, overall demand remains robust. While TAS performance was weak in the first quarter, it is expected to recover in the second half of the year.
- 05/23/2023
|
3 Stocks to Watch From a Promising Technology Services Industry
- The Zacks Technology Services industry seeks to benefit from increased digitization and dependency on technology, and the growing adoption of the multi-cloud model. TT, IQV and TSP are well-positioned to witness a demand surge.
- 05/05/2023
|
13 Stocks Pay You Very Well To Stay Invested In May
- Thinking about selling in May and staying away from the S&P 500? Not so fast.
- 05/02/2023
|
IQVIA Holdings (IQV) Surpasses Q1 Earnings & Revenue Estimates
- IQVIA Holdings (IQV) first-quarter 2023 revenues improve year over year.
- 04/27/2023
|
IQVIA Holdings (IQV) Tops Q1 Earnings and Revenue Estimates
- IQVIA Holdings (IQV) came out with quarterly earnings of $2.45 per share, beating the Zacks Consensus Estimate of $2.41 per share. This compares to earnings of $2.47 per share a year ago.
- 04/27/2023
|
Here's Why Investors Should Retain IQVIA Holdings (IQV) Stock
- Market size and data reserve are positives for IQVIA Holdings (IQV). Foreign currency risk is bothersome.
- 04/11/2023
|
IQVIA to Announce First-Quarter 2023 Results on April 27, 2023
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2023 financial results before the market opens on Thursday, April 27, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.
- 04/06/2023
|
50 Second Quarter Stocks to Watch
- Subscribers to Chart of the Week received this commentary on Sunday, April 2.
- 04/06/2023
|
IQVIA CFO Ron Bruehlman to Speak at Barclays Global Healthcare Conference on March 15, 2023
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays Global Healthcare Conference in Miami, FL on Wednesday, March 15, 2023 at 9:30 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day.
- 03/01/2023
|
Got $300? 3 Growth Stocks to Buy That Could Double Your Money
- All three companies have shown consistent revenue and EPS growth.
- 02/21/2023
|
IQVIA (IQV) Q4 Earnings and Revenues Beat Mark, Rise Y/Y
- IQVIA (IQV) fourth-quarter 2022 earnings and revenues surged year over year.
- 02/10/2023
|
IQVIA Holdings (IQV) Q4 2022 Earnings Call Transcript
- IQVIA Holdings (NYSE:IQV ) Q4 2022 Earnings Conference Call February 10, 2023 9:00 AM ET Company Participants Nick Childs - Senior Vice President, Investor Relations and Treasurer Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlman - Executive Vice President and Chief Financial Officer Eric Sherbet - Executive Vice President and General Counsel Mike Fedock - Senior Vice President, Financial Planning and Analysis Gustavo Perrone - Senior Director, Investor Relations Conference Call Participants Dan Leonard - Credit Suisse Eric Coldwell - Robert W. Baird Justin Bowers - Deutsche Bank Jack Meehan - Nephron Luke Sergott - Barclays Sandy Draper - Guggenheim Elizabeth Anderson - Evercore ISI Charles Rhyee - Cowen Operator Ladies and gentlemen, thank you for standing by.
- 02/10/2023
|
IQVIA Holdings (IQV) Beats Q4 Earnings and Revenue Estimates
- IQVIA (IQV) delivered earnings and revenue surprises of 1.09% and 0.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/10/2023
|
IQVIA: A Clear Case Of Why High ROIC Justifies High P/E Rating
- IQVIA continues to demonstrate its propensity to generate growth and future value for shareholders. Here, we peel back the layers to demonstrate the underlying economics in the company's business model.
- 01/26/2023
|
IQVIA to Announce Fourth-Quarter and Full-Year 2022 Results on February 10, 2023
- RESEARCH TRIANGLE PARK, N.C.--( BUSINESS WIRE )--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) will announce its fourth-quarter and full-year 2022 financial results before the market opens on Friday, February 10, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.
- 01/25/2023
|
IQVIA Holdings: Premium Valuation Is Justified For An Industry Leader
- IQVIA is one of my favorite investments thanks to it being one of the leading CROs with a broad array of services. IQVIA has over 10,000 customers including big pharma. I was concerned IQVIA was going to struggle following the pandemic, but they have continued to deliver strong financial marks and seem to expect significant growth in the coming years.
- 01/24/2023
|
IQVIA (IQV) Gains 10.4% in the Past 3 Months: Here's Why
- IQVIA (IQV) aims at market expansion through innovation and service improvements.
- 01/06/2023
|
Tesla is not alone: 18 (and a half) other big stocks are headed for their worst year on record
- In the worst year for stocks since the Great Recession, several big names are headed for their worst year on record with just one trading day left in 2022.
- 12/29/2022
|
3 Technology Services Stocks to Watch From a Promising Industry
- The Zacks Technology Services industry seeks to benefit from the increased digitization and dependency on technology and the growing adoption of the multi-cloud model. IQV, MTTR and TSP are well-positioned to witness a demand surge.
- 11/11/2022
|
IQVIA (IQV) Q3 Earnings and Revenues Beat Mark, Rise Y/Y
- IQVIA (IQV) third-quarter 2022 earnings and revenues surge year over year.
- 10/26/2022
|
IQVIA Holdings (IQV) Q3 2022 Earnings Call Transcript
- IQVIA Holdings (NYSE:IQV ) Q3 2022 Earnings Conference Call October 26, 2022 9:00 AM ET Company Participants Nick Childs - Senior Vice President, Investor Relations and Treasurer Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlman - Executive Vice President and Chief Financial Officer Conference Call Participants Dave Windley - Jefferies John Sourbeer - UBS Sandy Draper - Guggenheim Shlomo Rosenbaum - Stifel Justin Bowers - Deutsche Bank Patrick Donnelly - Citi Luke Sergott - Barclays Operator Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA Third Quarter 2022 Earnings Conference Call.
- 10/26/2022
|
Here's Why You Should Invest in IQVIA Holdings (IQV) Now
- IQVIA (IQV) aims at market expansion through innovation and service improvement.
- 10/12/2022
|
IQVIA (IQV) Loses 22.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- The heavy selling pressure might have exhausted for IQVIA (IQV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- 10/11/2022
|
IQV vs. CLBT: Which Stock Is the Better Value Option?
- IQV vs. CLBT: Which Stock Is the Better Value Option?
- 10/10/2022
|
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 10/10/2022
|
IQVIA to Announce Third-Quarter 2022 Results on October 26, 2022
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2022 financial results before the market opens on Wednesday, October 26, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the presentati
- 10/03/2022
|
The 7 Best Growth Stocks to Buy in October
- Amid fears of persistent inflation and economic slowdown, many growth names, especially those that aren't yet profitable, have fared poorly this year. However, growth stocks tend to outperform the broader market over the long term.
- 09/20/2022
|
IQVIA: Rebound Is Likely But Downtrend Is Still Intact (Technical Analysis)
- IQVIA Holdings Inc. bottomed on June 16 and has since rallied 28% in a breakout attempt that finally failed. IQVIA Holdings stock is a strong leader in its industry, and despite some recent weakness, has significantly outperformed the broader healthcare sector.
- 09/19/2022
|
Here's Why a Hold Strategy is Apt for IQVIA (IQV) Stock
- IQVIA's (IQV) enormous treasure trove of information is a distinguishing asset.
- 09/16/2022
|
Analysts Totally Blow It On 12 Gutsy Stock Recommendations
- Wall Street analysts follow S&P 500 stocks more closely than almost anyone. But even they get it wrong sometimes, too.
- 09/16/2022
|
Here's who could benefit from Biden's biotech initiative, according to Oppenheimer's Jared Holz
- Oppenheimer's Jared Holz on President Biden's cancer initiative and what it means for biotech in the U.S. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Courtney Garcia, Guy Adami and Karen Finerman.
- 09/12/2022
|
IQVIA CEO Ari Bousbib to Speak at Baird Global Healthcare Conference on September 14, 2022
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Baird 2022 Global Healthcare Conference in New York City on Wednesday, September 14, 2022 at 2:35 p.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day. About IQVIA IQVIA (NYSE:IQV) is
- 09/02/2022
|
IQVIA CFO Ron Bruehlman to Speak at Morgan Stanley Annual Global Healthcare Conference on September 13, 2022
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Morgan Stanley Annual Global Healthcare Conference in New York City on Tuesday, September 13, 2022 at 11:10 a.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day. Abou
- 09/01/2022
|
Reasons to Retain IQVIA Holdings (IQV) Stock in Your Portfolio
- IQVIA's (IQV) enormous treasure trove of information is a distinguishing asset.
- 08/15/2022
|
IQVIA: Resiliency And Quality Never Left, Q2 Earnings Evidence The Same
- Earnings quality and resiliency were on full display last quarter for IQVIA. The company continues to compound FCF at a long-term geometric average of 23%, with equally as high FCF ROE.
- 07/28/2022
|
IQVIA (IQV) Beats on Q2 Earnings & Revenues, Alters '22 View
- IQVIA's (IQV) second-quarter 2022 earnings and revenues surge year over year.
- 07/21/2022
|
IQVIA Holdings (IQV) CEO, Ari Bousbib on Q2 2022 Results - Earnings Call Transcript
- IQVIA Holdings Inc. (NYSE:IQV ) Q2 2022 Earnings Conference Call July 21, 2022 9:00 AM ET Company Participants Ari Bousbib - Chairman, Chief Executive Officer Ron Bruehlman - Executive Vice President, Chief Financial Officer Mike Fedock - Senior Vice President, Financial Planning and Analysis Nick Childs - Senior Vice President, Investor Relations and Corporate Communications Conference Call Participants Sandy Draper - Guggenheim Eric Coldwell - Baird Elizabeth Anderson - Evercore Derik de Bruin - Bank of America David Windley - Jefferies Jack Meehan - Nephron Research Adam - Stifel Tejas Savant - Morgan Stanley John Sourbeer - UBS Operator Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA second quarter 2022 earnings conference call.
- 07/21/2022
|
What's in the Offing for IQVIA Holdings (IQV) in Q2 Earnings?
- IQVIA Holdings' (IQV) second-quarter 2022 earnings and revenues are likely to have risen year over year.
- 07/18/2022
|
IQVIA Holdings (IQV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/14/2022
|
IQVIA to Announce Second-Quarter 2022 Results on July 21, 2022
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2022 financial results before the market opens on Thursday, July 21, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the presentation slid
- 07/07/2022
|
3 Biotech Stocks to Sell Now
- These biotech stocks remain vulnerable to more downside. Their charts remain broken and resistance looms ominously overhead.
- 07/05/2022
|
IQV vs. APP: Which Stock Should Value Investors Buy Now?
- IQV vs. APP: Which Stock Is the Better Value Option?
- 06/28/2022
|
7 Biotech Stocks With Key Catalysts Coming in July
- Biotech stocks have suffered significant setbacks during the first half of the year but are likely to bounce back soon The post 7 Biotech Stocks With Key Catalysts Coming in July appeared first on InvestorPlace. More From InvestorPlace $200 Oil Sooner Than You Think – Buy This Now The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn't matter if you have $500 in savings or $5 million.
- 06/27/2022
|
Why a Hold Strategy is Apt for IQVIA Holdings (IQV) Stock Now
- IQVIA's (IQV) enormous treasure trove of information is a distinguishing asset.
- 06/24/2022
|
Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now
- IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.
- 05/31/2022
|
Why Is IQVIA (IQV) Down 5.3% Since Last Earnings Report?
- IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
- 05/27/2022
|
Karen Firestone's top stock picks: Vertex Pharma, Moderna
- Kari Firestone, Aureus Asset Management, joins 'Closing Bell: Overtime' to discuss the biotech bounce and her top stock picks.
- 05/13/2022
|
IQVIA (IQV) Strong on IT Infrastructure Despite Debt Woes
- IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.
- 05/13/2022
|
Elfun Trusts Storms Into Netflix, IQVIA in 1st Quarter
- Elfun Trusts (Trades, Portfolio), part of Boston-based State Street Global Advisors, disclosed its first quarter portfolio this week, revealing that its top five trades included new holdings in Netflix Inc. ( NFLX , Financial) and IQVIA Holdings Inc. ( IQV , Financial), reductions to its positions in Mondelez International Inc. ( MDLZ , Financial) and JPMorgan Chase & Co. ( JPM , Financial) and the closure of its position in Sempra Energy ( SRE , Financial).
- 05/05/2022
|
IQVIA A Smart Choice In A High-Inflation Environment
- IQVIA has the potential to outperform the market in a higher inflation environment. Significant growth potential with projected 17.72% FCF and 11.68% EBIT CAGR over the next 5 years.
- 04/29/2022
|
IQVIA (IQV) Beats on Q1 Earnings & Revenues, Tweaks '22 View
- IQVIA's (IQV) first-quarter 2022 earnings and revenues increase year over year.
- 04/27/2022
|
IQVIA Holdings Inc.'s (IQV) CEO Ari Bousbib on Q1 2022 Results - Earnings Call Transcript
- IQVIA Holdings Inc. (NYSE:IQV ) Q1 2022 Earnings Conference Call April 27, 2022 9:00 AM ET Company Participants Nick Childs - Senior Vice President, Investor Relations and Corporate Communications Ari Bousbib - Chairman and Chief Executive Officer Ron Bruehlman - Executive Vice President and Chief Financial Officer Mike Fedock - Senior Vice President, Financial Planning and Analysis Conference Call Participants Eric Coldwell - Baird Shlomo Rosenbaum - Stifel Nicolaus Jack Meehan - Nephron John Sourbeer - UBS Luke Sergott - Barclays Patrick Donnelly - Citi Operator Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to the IQVIA First Quarter 2022 Earnings Conference Call.
- 04/27/2022
|
IQVIA to Announce First-Quarter 2022 Results on April 27, 2022
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2022 financial results before the market opens on Wednesday, April 27, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the presentation sli
- 04/12/2022
|
3 Technology Services Stocks to Watch Despite Industry Challenges
- The coronavirus-driven dependency on technology, increased digitization and growing adoption of the multi-cloud model should help the Zacks Technology Services industry thrive. IQV, BCOR and AQUA are well-positioned to witness a demand surge.
- 04/06/2022
|
Here's Why You Should Retain IQVIA Holdings (IQV) Stock For Now
- IQVIA (IQV) has a growing client base, along with the ability to standardize, organize and integrate its enormous treasure trove of data.
- 04/01/2022
|
3 Stock Picks for a Long-Term Investment Approach
- The GuruFocus business predictability rating ranks companies on a five-star scale, defining the more predictable companies as businesses whose revenue per share and Ebitda per share (or book value per share in the case of financial stocks) have been growing steadily and who have produced a strong long-term performance of their stock prices.
- 03/23/2022
|
IQVIA CFO to Speak at Barclays Global Healthcare Conference on March 16, 2022
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays Global Healthcare Conference in Miami, FL on Wednesday, March 16, 2022 at 1:35 p.m. ET. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day. About IQVIA IQVIA (NYSE:
- 03/03/2022
|
IQVIA (IQV) Rides on Global IT Infrastructure, Debt Remains High
- IQVIA's (IQV) combined offerings of research and development, and commercial services help it build a strong client base.
- 03/02/2022
|
IQVIA: Intelligent Healthcare Solutions For A Growing Market
- IQVIA is a recognized leader in providing advanced tech solutions to companies in the life sciences industry.
- 02/19/2022
|
IQVIA (IQV) Q4 Earnings & Revenues Beat Estimates, Rise Y/Y
- IQVIA's (IQV) fourth-quarter 2021 earnings and revenues increase year over year.
- 02/15/2022
|
IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q4 2021 Results - Earnings Call Transcript
- IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q4 2021 Results - Earnings Call Transcript
- 02/15/2022
|
IQVIA Holdings (IQV) Surpasses Q4 Earnings and Revenue Estimates
- IQVIA (IQV) delivered earnings and revenue surprises of 4.94% and 1.16%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/15/2022
|
The Pros' 10 Best S&P 500 Stocks to Buy Now
- Analysts are upbeat toward S&P 500 stocks for 2022, though some of the optimism has moderated following a volatile start to the year. Between talk of higher interest rates on the way to the wind-down of the "stay-at-home trade" that drove returns in 2021, investors have repositioned themselves for what could turn out to be a very different year on Wall Street.
- 02/14/2022
|
Five Stocks Wall Street Just Loves for Valentine's Day
- Wall Street has stars in its eyes over certain stocks. That isn't a guarantee of great performance, but three of five of the Street's favorites in 2021 beat the market over the past year.
- 02/14/2022
|
What's in the Cards for IQVIA Holdings' (IQV) in Q4 Earnings?
- IQVIA Holdings' (IQV) fourth-quarter 2021 earnings and revenues are likely to have increased year over year.
- 02/11/2022
|
Final Trades: Nvidia, Wynn, IQVIA
- The "Halftime Report" traders give their top picks to watch for the second half.
- 02/10/2022
|
IQVIA Holdings (IQV) Earnings Expected to Grow: What to Know Ahead of Q4 Release
- IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 02/02/2022
|
IQVIA to Announce Fourth-Quarter and Full-Year 2021 Results on February 15, 2022
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) will announce its fourth-quarter and full-year 2021 financial results before the market opens on Tuesday, February 15, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the
- 02/01/2022
|
IQVIA Holdings (IQV) Stock Up 34.4% In a Year: Here's Why
- Consecutive better-than-expected top- and bottom-line performances and shareholder-friendly moves have been aiding IQVIA Holdings (IQV) stock.
- 01/11/2022
|
Oppenheimer healthcare strategist on why he likes the CRO space in 2022
- Jared Holz, Oppenheimer healthcare strategist, joins 'Power Lunch' to discuss the healthcare sector and why biotech companies could struggle the most in the space. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC Turn to CNBC TV for the latest stock market news and analysis.
- 12/28/2021
|
Tired of Metaverse Mania? 3 Growth Stocks That Are Great Buys Right Now
- Been missing out on other hot growth trends? Get real.
- 12/11/2021
|
3 Technology Services Stocks to Watch Despite Industry Challenges
- The Zacks Technology Services industry is likely to benefit from COVID-19-driven dependency on technology, increased digitization and adoption of the multi-cloud model. IQV, STX and BCOR are well positioned to witness the demand surge.
- 12/01/2021
|
IQVIA (IQV) Riding on Global IT Infrastructure, Debt Woe Stays
- IQVIA's (IQV) combined offerings of research and development, and commercial services help it build a strong client base.
- 11/12/2021
|
IQVIA Holdings, Inc. (IQV) CEO Ari Bousbib on Q3 2021 Results - Earnings Call Transcript
- IQVIA Holdings, Inc. (IQV) CEO Ari Bousbib on Q3 2021 Results - Earnings Call Transcript
- 10/21/2021
|
IQVIA Holdings' Beat On Q3 Earnings, Raises FY21 Outlook
- IQVIA Holdings Inc (NYSE: IQV) has posted Q3 adjusted EPS of $2.17, up 33% Y/Y, marginally surpassing the consensus of $2.12 Revenue of $3.4 billion increased 21.7% on a reported basis and 21.1 percent at constant currency, ahead of the consensus of $3.35 billion.
- 10/21/2021
|
IQVIA Holdings (IQV) Earnings Expected to Grow: What to Know Ahead of Q3 Release
- IQVIA (IQV) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/12/2021
|
IQVIA to Host Financial Analyst and Investor Conference on November 16, 2021
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will host an Analyst and Investor Conference in New York City on Tuesday, November 16, 2021. Management will provide an update on the business, with presentations starting at 10:00 a.m. ET and concluding at approximately 12:30 p.m. ET. Registration is required to attend the event. The live event, including presentation slides, will be available via webcast. Login information will be provided on the IQVIA In
- 10/07/2021
|
LGI: Interesting Closed-End Fund At A Wider Discount
- LGI: Interesting Closed-End Fund At A Wider Discount
- 10/05/2021
|
Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now
- Solid shareholder-friendly measures and strong healthcare-specific global IT infrastructure boost IQVIA Holdings (IQV) shares.
- 09/27/2021
|
IQVIA Holdings' (IQV) Stock Up 44% Year to Date: Here's Why
- Encouraging yearly guidance and consecutive better-than-expected top- and bottom-line performances have been aiding IQVIA Holdings' (IQV) stock.
- 09/17/2021
|
IQVIA and NRx Pharmaceuticals Collaborate on Potential Medical Support for Novel COVID-19 Treatment
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a transformative collaboration with NRx Pharmaceuticals (NRx) (Nasdaq: NRXP). NRx is a company dedicated to creating innovative, life-saving treatments and bringing hope to those facing life-altering conditions with no approved disease-modifying therapies or cures. IQVIA is excited to
- 09/13/2021
|
IQVIA Collaborates with HealthCore to Advance Clinical Research Using Real-World Data
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) announces its strategic collaboration with HealthCore, Inc., a leading real world research organization in the United States, to advance real world evidence (RWE) studies with increased quality and efficiency. RWE studies incorporate innovative scientific methods with dynamic data from sources such as electronic medical records, pharmacy and medical claims, laboratory and genomics records, and patient-reported outcomes. “IQVIA is
- 09/08/2021
|
IQVIA (IQV) Banking on Global IT Infrastructure, Debt Woe Stays
- IQVIA's (IQV) combined offerings of research and development, and commercial services help it build a strong client base.
- 08/20/2021
|
IQVIA: Market Crosscurrents In Clinical And Adjacent Markets
- IQVIA is well-positioned to capitalise on market crosscurrents in its end-markets, with tech integration accelerated from the pandemic. Second quarter revenues came in well above consensus and illustrate the foundation IQV will work on for the remainder of FY2021.
- 07/29/2021
|
IQVIA (IQV) Beats on Q2 Earnings & Revenues, Raises 2021 View
- IQVIA's (IQV) second-quarter 2021 earnings and revenues increase year over year.
- 07/27/2021
|
IQVIA Holdings, Inc. (IQV) CEO Ari Bousbib on Q2 2021 Results - Earnings Call Transcript
- IQVIA Holdings, Inc. (IQV) CEO Ari Bousbib on Q2 2021 Results - Earnings Call Transcript
- 07/27/2021
|
IQVIA Holdings (IQV) Surpasses Q2 Earnings and Revenue Estimates
- IQVIA (IQV) delivered earnings and revenue surprises of 2.90% and 5.45%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/27/2021
|
What's in Store for IQVIA Holdings (IQV) in Q2 Earnings?
- IQVIA's (IQV) second-quarter 2021 earnings and revenues are expected to have improved year over year.
- 07/23/2021
|
Look Inside Hot Products For Transformational Growth Stocks
- Look Inside Hot Products For Transformational Growth Stocks
- 07/21/2021
|
3 Technology Services Stocks to Watch Out For Despite Industry Woes
- The coronavirus-driven dependency on technology, increased digitization and growing adoption of the multi-cloud model should help the Zacks Technology Services industry thrive. IQV, STX and BCOR are well positioned to witness demand surge.
- 07/21/2021
|
IQVIA to Announce Second-Quarter 2021 Results on July 27, 2021
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its second-quarter 2021 financial results before the market opens on Tuesday, July 27, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the presentation slide
- 07/13/2021
|
Here's Why You Should Retain IQVIA Holdings (IQV) Stock For Now
- IQVIA's (IQV) unique ability to standardize, organize and integrate information through applying sophisticated analytics and global technology infrastructure helps it build a strong client base.
- 07/07/2021
|
IQVIA (IQV) Announces Launch of Clinical Data Analytics Suite
- IQVIA's (IQV) new platform brings benefits such as real-time data management, reduced data-harmonization efforts, reduced time of KPI deployment and improved decision making.
- 06/25/2021
|
IQVIA Holdings (IQV) Stock Up 55.4% Over a Year: Here's Why
- IQVIA Holdings (IQV) stock is riding on consecutive better-than-expected top- and bottom-line performances, and an encouraging yearly guidance.
- 06/08/2021
|
Global Oncology Innovation Continues Despite Pandemic; Global R&D Pipeline Reached 3,500 New Drugs in 2020, up 75% from 2015, Says New Report from the IQVIA Institute for Human Data Science
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Despite the substantial impact of the COVID-19 pandemic on patient care during 2020, the scientific advances in oncology continued, with 3,500 new drugs in the pipeline in 2020, up 75 percent since 2015. Oncologists worldwide report caseloads that are 26 to 51 percent lower than pre-pandemic levels, resulting in delays in necessary treatments. Despite this, the surge in innovative cancer medicines continued, as reflected in clinical trial activity,
- 06/03/2021
|
IQVIA Holdings (IQV) Hits 52-Week High: What's Driving It?
- Consecutive better-than-expected top- and bottom-line performances, along with an encouraging yearly guidance, have been aiding IQVIA Holdings (IQV) stock.
- 05/24/2021
|
IQVIA CFO, Ron Bruehlman, to Speak at the William Blair Growth Stock Conference on June 2, 2021
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in a virtual fireside chat at the William Blair Growth Stock Conference on Wednesday, June 2, 2021 at 10:20 a.m. EDT. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day. Abou
- 05/20/2021
|
Here is Why Growth Investors Should Buy IQVIA (IQV) Now
- IQVIA (IQV) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- 05/20/2021
|
Pharma R&D Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Despite significant disruption and reprioritization of clinical trial activity during 2020 due to COVID-19, R&D activity levels remained at historically high levels, driven by new funding and strategic transactions, especially within oncology, according to a new research report Global Trends in R&D: Overview Through 2020 released by the IQVIA™ Institute for Human Data Science. “The growth in research and development driven by new oncology d
- 05/19/2021
|
Stock Market Has Quiet Day; Iqvia Setting Up, SM Energy Fizzles, Palantir Still Looks Weak
- Stock market has quiet day; Iqvia setting up, SM Energy fizzles, Palantir still looks weak. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
- 05/18/2021
|
How To Trade These 7 Healthcare Stocks and ETF Says 2ndSkiesForex's Chris Capre
- The Benzinga Global Small Cap Conference on May 13 featured presentations from publicly-traded companies and educational segments for investors. Among the featured segments was one from Chris Capre on how to trade healthcare trends.
- 05/14/2021
|
3 Reasons Why Growth Investors Shouldn't Overlook IQVIA (IQV)
- IQVIA (IQV) could produce exceptional returns because of its solid growth attributes.
- 05/03/2021
|
IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q1 2021 Results - Earnings Call Transcript
- IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q1 2021 Results - Earnings Call Transcript
- 04/22/2021
|
IQVIA (IQV) Beats on Q1 Earnings & Revenues, Raises 2021 View
- IQVIA's (IQV) first-quarter 2021 earnings and revenues increase year over year.
- 04/22/2021
|
IQVIA Reports First-Quarter Results; Raises Full-Year 2021 Guidance
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA revenue for the first quarter of $3,409 million increased 23.8 percent on a reported basis and 21.4 percent at constant currency
- 04/22/2021
|
What's in Store for IQVIA Holdings (IQV) in Q1 Earnings?
- IQVIA's (IQV) first-quarter 2021 earnings and revenues are expected to have improved year over year.
- 04/20/2021
|
IQVIA Holdings (IQV) Hits 52-Week High: What's Driving It?
- IQVIA Holdings (IQV) has been benefiting from consecutive better-than-expected top- and bottom-line performances, and encouraging yearly EPS guidance.
- 04/07/2021
|
IQVIA to Announce First-Quarter 2021 Results on April 22, 2021
- RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its first-quarter 2021 financial results before the market opens on Thursday, April 22, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com. To listen to the event and view the presentation slid
- 04/06/2021
|
IQVIA (IQV) Hits 52-Week High, Can the Run Continue?
- IQVIA (IQV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 04/06/2021
|
IQVIA (IQV) Buys Remaining Q2 Solutions Stake, Ups EPS View
- The latest deal is expected to help IQVIA (IQV) strengthen its Research & Development Solutions segment.
- 04/05/2021
|
Quest Diagnostics Sells Ownership Interest in Q² Solutions to IQVIA
- SECAUCUS, N.J. and RESEARCH TRIANGLE PARK, N.C.
- 04/01/2021
|
Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now
- IQVIA Holdings (IQV) rises on consistent shareholder-friendly measures and strong healthcare-specific infrastructures. Meanwhile,the company's debt-laden balance sheet is a concern.
- 03/16/2021
|
Why Is IQVIA (IQV) Down 1.8% Since Last Earnings Report?
- IQVIA (IQV) reported earnings 30 days ago. What's next for the stock?
- 03/12/2021
|
IQVIA to Participate in the Barclays Global Healthcare Conference on March 09, 2021
- DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in a virtual fireside chat at the Barclays Global Healthcare Conference on Tuesday, March 09, 2021 at 3:00 p.m. EST. A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast also will be available
- 03/02/2021
|
IQVIA (IQV) Rides on Life Sciences Strength, Debt Woes Stay
- IQVIA (IQV) has a strong healthcare-specific global IT infrastructure, analytics-driven clinical development capabilities and a robust real-world solutions ecosystem.
- 02/25/2021
|
IQVIA Announces Pricing of Offering of Senior Notes
- DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €1,450,000,000 in aggregate principal amount of senior notes, consisting of €550,000,000 in aggregate principal amount of senior notes due 2026 (the “2026 Notes”) and €900,000,000 in aggregate principal amount of senior notes due 2029 (the “2029 Notes” and, together with the 2026 Notes, the “No
- 02/17/2021
|
PPD May See Durable Growth From Virus Study Revenue
- PPD May See Durable Growth From Virus Study Revenue
- 02/16/2021
|
IQVIA's Orchestrated Customer Engagement (OCE) Solution Selected by 140 Life Sciences Companies in Nearly 90 Countries
- DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) today announced that 140 life science companies in nearly 90 countries have selected Orchestrated Customer Engagement (OCE) as their customer engagement solution. This milestone reflects the growing demand within the market for IQVIA's commercial technology to meet the evolving needs of life science companies. Most recently, Laboratoires Théa, a leading independent eye care group in Europe, has joined the growing l
- 02/11/2021
|
IQVIA Holdings Inc.'s (IQV) CEO Ari Bousbib on Q4 2020 Results - Earnings Call Transcript
- IQVIA Holdings Inc.'s (IQV) CEO Ari Bousbib on Q4 2020 Results - Earnings Call Transcript
- 02/10/2021
|
IQVIA (IQV) Beats on Q4 Earnings & Revenues, Raises 2021 View
- IQVIA's (IQV) fourth-quarter 2020 revenues and earnings increase year over year.
- 02/10/2021
|
IQVIA Holdings (IQV) Q4 Earnings and Revenues Beat Estimates
- IQVIA (IQV) delivered earnings and revenue surprises of 4.98% and 4.68%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/10/2021
|
What's in Store for IQVIA Holdings (IQV) in Q4 Earnings?
- IQVIA's (IQV) fourth-quarter 2020 earnings and revenues are expected to have improved year over year.
- 02/08/2021
|
IQVIA Recognized as Leading eCOA/ePRO Provider in Latest 2020 ISR eCOA/ePRO Market Report
- DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) today announced that it has been recognized as a top performer by survey respondents in Industry Standard Research's eCOA/ePRO Market Dynamics and Service Provider Performance (4th Edition) report for overall performance, capabilities, cost, system flexibility and support, system/device integration, and validation and patient compliance. Survey respondents also recognized IQVIA as the No. 1 electronic Clinical Ou
- 02/04/2021
|
My Best SaaS Stock for 2021
- Veeva Systems could double its annual revenue over the next four years.
- 01/20/2021
|
IQVIA Holdings: Upside Potential, Key Levers Overlooked By Sell-Side
- IQVIA demonstrates a strong sequential growth pattern, in near recovery to pre-pandemic volumes. Management have reinstated the buyback program, with ~$1 billion in authorization, and look set on acquisition targeting across FY2021.
- 01/13/2021
|
Notable Insider Buys Of The Past Week: Danimer Scientific, Cheniere Energy Partners And More
- Conventional wisdom says that insiders and 10% owners really only buy shares of a company for one reason — they believe the stock price will rise and they want to profit from it. So insider buying can be an encouraging signal for potential investors, particularly when there is uncertainty in the markets, as there has been due to the pandemic resurgence and political issues.
- 01/02/2021
|
IQVIA and Servier Collaborate to Reinvent Clinical Development
- DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a collaboration with Servier, an independent global pharmaceutical company, to reinvent their R&D clinical development processes and support their long-term R&D success. Servier has ambitious plans for growth and is committed to therapeutic progress to serve p
- 12/16/2020
|
IQVIA Supports Collaborative Forum of Top Pharma Leaders to Advance the Use and Acceptance of Real World Evidence
- DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV) said today that it is pleased to be a supporter of the Real World Evidence Leadership Forum, a group consisting of senior RWE executives from 18 major pharmaceutical companies. The forum acts as a non-competitive collaboration to understand, discuss and respond to internal and external RWE challenges and opportunities with a single expert voice and the aim of improving outcomes for patients globally. “As the worl
- 12/07/2020
|
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
- Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
- 09/04/2020
|
Tracking Dan Loeb's Third Point Portfolio - Q2 2020 Update
- Dan Loeb's 13F portfolio value increased from $6.27B to $7.30B this quarter. The number of positions increased from 30 to 36.
- 08/28/2020
|
Top Insider Buys Highlight for the Week of August 7
- The largest Insider Buys this week were for Boeing Co., IQVIA Holdings Inc., Schlumberger Ltd. and Elanco Animal Health Inc. Continue reading...
- 08/08/2020
|
Notable Insider Buys at Allovir, Xerox And Many More
- Insider buying can be an encouraging signal for potential investors during periods of uncertainty.
A notable activist investor added to his stake in an old-school tech company....
- 08/08/2020
|
IQVIA’s Nancy Dreyer and Deepa Desai Honored with 2020 PharmaVOICE Awards
- IQVIA™ (NYSE: IQV) today announced that Nancy Dreyer, chief scientific officer and senior vice president, Real World Solutions, has been awarded PharmaVOICE magazine’s Red Jacket honor after she was recognized multiple times as a PharmaVOICE 100. IQVIA’s Deepa Desai, vice president and head, Quality Management Systems, Quality Assurance, was honored on the 2020 PharmaVOICE 100 List, which identifies the most influential and inspiring leaders within the life sciences industry.
- 08/05/2020
|
Drug Prices Have Become More Affordable to Most Patients, says U.S. Medicine Spending Study from the IQVIA Institute for Human Data Science
- The vast majority of patients in the United States are experiencing lower out-of-pocket costs for their drugs, paying a smaller share of costs and seeing a downward trend in their costs on average. That’s according to the latest report from The IQVIA™ Institute for Human Data Science, Medicine Spending and Affordability in the U.S.: Understanding Patient Costs for Medicines. The improved affordability for patients is due to changes in health insurance benefit design, a higher use of generics, record low price increases on branded drugs and more patients reaching "catastrophic" coverage levels.
- 08/04/2020
|
Insiders Roundup: Tetraphase Pharmaceuticals, Bank of America
- Largest insider trades of the week Continue reading...
- 07/31/2020
|
IQV vs. SSTI: Which Stock Should Value Investors Buy Now?
- IQV vs. SSTI: Which Stock Is the Better Value Option?
- 07/30/2020
|
IQVIA Launches OCE Optimizer to Help Intelligently Plan HCP Engagements and Maximize Commercial Effectiveness
- IQVIA™ (NYSE: IQV) today introduced OCE Optimizer, an innovative solution that empowers life sciences companies to plan and refine marketing engagements with healthcare providers (HCPs) on demand. OCE Optimizer extends IQVIA’s Orchestrated Customer Engagement solution by intelligently allocating commercial resources and interaction channels for more effective connections.
- 07/29/2020
|
Ari Bousbib Sells 46,080 Shares of Iqvia Holdings Inc (NYSE:IQV) Stock
- Iqvia Holdings Inc (NYSE:IQV) insider Ari Bousbib sold 46,080 shares of Iqvia stock in a transaction that occurred on Wednesday, July 22nd. The stock was sold at an average price of $160.00, for a total transaction of $7,372,800.00. Following the transaction, the insider now owns 698,115 shares in the company, valued at $111,698,400. The transaction […]
- 07/27/2020
|
Earnings Update: Here's Why Analysts Just Lifted Their IQVIA Holdings Inc. (NYSE:IQV) Price Target To US$179
- Investors in IQVIA Holdings Inc. (NYSE:IQV) had a good week, as its shares rose 2.5% to close at US$158 following the...
- 07/25/2020
|
IQVIA Human Data Science Research Collaborative Initiative Waives Data Access Fees for Academic Researchers
- IQVIA™ (NYSE: IQV) announced a new Human Data Science Research Collaborative initiative that is waiving licensing and access fees for approved academic researchers around the world to use two IQVIA data technology platforms and analytics from multiple countries to accelerate research addressing challenges and opportunities for health systems in the COVID-19 era.
- 07/23/2020
|
IQVIA Holdings Inc. (IQV) Q2 2020 Earnings Call Transcript
- IQV earnings call for the period ending June 30, 2020.
- 07/22/2020
|
Coronavirus update: U.S. case tally climbs above 3.9 million as Trump finally urges Americans to wear face masks
- The number of U.S. cases of the coronavirus illness COVID-19 climbed above 3.9 million on Wednesday, a day after President Donald Trump finally encouraged...
- 07/22/2020
|
A Look Into IQVIA's Price Over Earnings
- In the current session, IQVIA Holdings Inc. (NYSE: IQV) is trading at $163.31, after a 4.09% increase. Over the past month, the stock increased by 19.49%, and in the past year, by 1.86%. With performance like this, long-term shareholders optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.Assuming that all other factors are held constant, this could present itself as an opportunity for shareholders trying to capitalize on the higher share price. The stock is currently below from its 52 week high by 3.45%.The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E indicates that shareholders do not expect the stock to perform better in the future, and that the company is probably undervalued. It shows that shareholders are less than willing to pay a high share price, because they do not expect the company to exhibit growth, in terms of future earnings.View more earnings on IQVDepending on the particular phase of a business cycle, some industries will perform better than others.Compared to the aggregate P/E ratio of 81.13 in the Diagnostics & Research industry, IQVIA Holdings Inc. has a higher P/E ratio of 143.99. Shareholders might be inclined to think that IQVIA Holdings Inc. might perform better than its industry group. It's also possible that the stock is overvalued.There are many limitations to price to earnings ratio. It is sometimes difficult to determine the nature of the earnings makeup of a company. Shareholders might not get what they're looking for, from trailing earnings.See more from Benzinga * IQVIA Holdings: Q2 Earnings Insights * Earnings Scheduled For July 22, 2020(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 07/22/2020
|
IQVIA (IQV) Beats on Q2 Earnings, Revenues, Ups 2020 View
- IQVIA's (IQV) second-quarter 2020 revenues and earnings decrease year over year.
- 07/22/2020
|
IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q2 2020 Results - Earnings Call Transcript
- IQVIA Holdings Inc. (NYSE:IQV) Q2 2020 Earnings Conference Call July 22, 2020, 09:00 AM ET Company Participants Andrew Markwick - SVP, IR and Treasury Ari Bousbib - Chairman and CEO Michael McDonnell - EVP and CFO Eric Sherbet - EVP and General Counsel Nick Childs - SVP, Financial Planning and Analysis Jen Halchak - Senior Director, IR Conference Call Participants George Hill - Deutsche Bank Tycho Peterson - JPMorgan Robert Jones - Goldman Sachs Patrick Donnelly - Citi Eric Coldwell - Baird Presentation Operator Ladies and gentlemen, thank you for standing by.
- 07/22/2020
|
IQVIA Holdings Inc. 2020 Q2 - Results - Earnings Call Presentation
- The following slide deck was published by IQVIA Holdings Inc. in conjunction with their 2020 Q2 earnings call..
- 07/22/2020
|
IQVIA Holdings (IQV) Q2 Earnings and Revenues Beat Estimates
- IQVIA (IQV) delivered earnings and revenue surprises of 12.38% and 4.80%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 07/22/2020
|
IQVIA Holdings: Q2 Earnings Insights
- Shares of IQVIA Holdings (NYSE:IQV) fell 1.6% in pre-market trading after the company reported Q2 results.Quarterly Results Earnings per share fell 22.88% over the past year to $1.18, which beat the estimate of $1.06.Revenue of $2,521,000,000 declined by 7.99% from the same period last year, which beat the estimate of $2,410,000,000.Outlook The upcoming fiscal year's EPS expected to be between $6.10 and $6.30.The upcoming fiscal year's revenue expected to be between $11,000,000,000 and $11,100,000,000.How To Listen To The Conference Call Date: Jul 22, 2020View more earnings on IQVTime: 09:00 AMET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fir.iqvia.com%2Fevents-and-presentations%2Fdefault.aspx&eventid=2395789&sessionid=1&key=C8C68C988BD54CBEAF0A22ED2AA35A7E®Tag=&sourcepage=registerTechnicals Company's 52-week high was at $169.14Company's 52-week low was at $81.79Price action over last quarter: Up 9.68%Company Description IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The CRO segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The legacy IMS business provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers.See more from Benzinga * Earnings Scheduled For July 22, 2020(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 07/22/2020
|
Biogen's stock rises after big earnings beat, raised outlook
- Shares of Biogen Inc. undefined rose 1.4% in premraket trading Wednesday, after the biotechnology company reported second-quarter profit that rose well above...
- 07/22/2020
|
Biogen's stock rises after big earnings beat, raised outlook
- Shares of Biogen Inc. rose 1.4% in premraket trading Wednesday, after the biotechnology company reported second-quarter profit that rose well above expectations, and raised the full-year outlook. Net income grew to $1.54 billion, or $9.59 a share, from $1.49 billion, or $7.85 a share, in the year-ago period. Excluding non-recurring items, adjusted earnings per share increased to $10.26 from $9.15, beating the FactSet consensus of $8.02. Revenue rose 2% to $3.68 billion, above the FactSet consensus of $3.43 billion. Among Biogen's biggest-selling drug products, Tecfidera revenue rose 3% to $1.18 billion, above the FactSet consensus of $1.11 billion; Spinraza revenue rose 1% to $495 million, below expectations of $506 million; and Tysabri revenue fell 9% to $432 million to miss expectations of $445 million. For 2020, Biogen raised its adjusted EPS guidance range to $34.00 from $36.00 from $31.50 to $33.50, compared with the FactSet consensus of $33.07, but lowered its revenue outlook to $13.8 billion to $14.2 billion from $14.0 billion to $14.3 billion, compared with expectations of $13.94 billion. The earnings report comes after Biogen announced late Tuesday that Chief Financial Officer Jeffrey Capello will step down next month, and be succeeded by Iqvia Holdings Inc.'s current CFO Michael McDonnell. The stock has lost 5.6% year to date through Tuesday, while the iShares Nasdaq Biotechnology ETF has run up 18.2% and the S&P 500 has edged up 0.8%.
- 07/22/2020
|
IQVIA Reports Second-Quarter 2020 Results and Raises Full-Year 2020 Guidance
- IQVIA Reports Second-Quarter 2020 Results and Raises Full-Year 2020 Guidance
- 07/22/2020
|
Valeo Financial Advisors LLC Sells 90 Shares of Iqvia Holdings Inc (NYSE:IQV)
- Valeo Financial Advisors LLC reduced its position in shares of Iqvia Holdings Inc (NYSE:IQV) by 3.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,480 shares of the medical research company’s stock after selling 90 shares during the quarter. Valeo Financial […]
- 07/22/2020
|
Biogen Taps Iqvia CFO as New Finance Chief
- Drugmaker Biogen has named Michael McDonnell, the current finance chief at drug-testing and data company Iqvia Holdings Inc., as its next chief financial officer.
- 07/22/2020
|
IQVIA Appoints Ron Bruehlman Executive Vice President and interim Chief Financial Officer | | IT Business Net
- DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and contr
- 07/22/2020
|
Global Life Science Analytics Software Market 2020-2027 by Product, Application, Delivery Model, End-user and Region - ResearchAndMarkets.com
|
Biogen names Michael McDonnell as new CFO
- Biogen Inc. undefined said late Tuesday that Michael McDonnell will become chief financial officer on Aug. 15. Currently, McDonnell serves as CFO at...
- 07/21/2020
|
Biogen names Michael McDonnell as new CFO
- Biogen Inc. said late Tuesday that Michael McDonnell will become chief financial officer on Aug. 15. Currently, McDonnell serves as CFO at life-sciences company Iqvia Holdings Inc. . Biogen's current CFO, Jeffrey Capello, will step down in mid-August and remain with the company until Sept. 15 to assist in the transition.
- 07/21/2020
|
Biogen Names Michael McDonnell as Executive Vice President and Chief Financial Officer
- CAMBRIDGE, Mass., July 21, 2020 -- Biogen Inc. (Nasdaq: BIIB) announced today the appointment of Michael (Mike) McDonnell as Executive Vice President and Chief Financial.
- 07/21/2020
|
IQVIA Appoints Ron Bruehlman Executive Vice President and interim Chief Financial Officer
- IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and contract services to the life sciences industry, today announced the appointment of Ron Bruehlman as Executive Vice President and interim Chief Financial Officer, succeeding Mike McDonnell who is leaving the company to become Chief Financial Officer of Biogen Inc.
- 07/21/2020
|
Here's the device the NFL and NBA are using for coronavirus contact tracing and social distancing
- The NFL and NBA are using Kinexon's SafeZone tag as a tool that to monitor social distancing and for contact tracing
- 07/21/2020
|
IQVIA and JDRF Collaborate to Improve Understanding of Type 1 Diabetes Using Real World Data
- IQVIA™ (NYSE: IQV) today announced it is joining forces with JDRF, the leading global organization funding type 1 diabetes (T1D) research, to use non-identified patient-level, real world data and analytics to address unmet needs in the diabetes community.
- 07/20/2020
|
IQVIA and JDRF Collaborate to Improve Understanding of Type 1 Diabetes Using Real World Data
- IQVIA™ (NYSE: IQV) today announced it is joining forces with JDRF, the leading global organization funding type 1 diabetes (T1D) research, to use non-
- 07/20/2020
|
Exchange Traded Concepts LLC Acquires 1,215 Shares of Iqvia Holdings Inc (NYSE:IQV)
- Exchange Traded Concepts LLC raised its holdings in shares of Iqvia Holdings Inc (NYSE:IQV) by 113.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,290 shares of the medical research company’s stock after purchasing an additional 1,215 shares during the quarter. Exchange […]
- 07/19/2020
|
IQVIA (IQV) to Report Q2 Earnings: What's in the Cards?
- IQVIA's (IQV) second-quarter 2020 results are likely to reflect coronavirus-led decline in the top and bottom lines.
- 07/17/2020
|
IQVIA Holdings Inc. : half-yearly earnings release | MarketScreener
|
Analysts Estimate IQVIA Holdings (IQV) to Report a Decline in Earnings: What to Look Out for
- IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/15/2020
|
AstraZeneca ties up with IQVIA to speed up studies of COVID-19 vaccine candidate
- The collaboration is part of the U.S. government's Operation Warp Speed to accelerate the development of COVID-19 vaccines and treatments. AstraZeneca is among the drugmakers farthest along in the race to develop a safe and effective vaccine for COVID-19, the respiratory disease caused by the new coronavirus.
- 07/14/2020
|
IQVIA : Says Working With AstraZeneca to Accelerate Potential Covid-19 Vaccine | MarketScreener
|
IQVIA : and AstraZeneca Team-up to Support Development of Potential COVID-19 Vaccine | MarketScreener
|
IQVIA and AstraZeneca Team-up to Support Development of Potential COVID-19 Vaccine
- IQVIA™ (NYSE:IQV) has announced its collaboration with AstraZeneca (LON: AZN) to accelerate development of a potential new vaccine for COVID-19. This joint initiative is part of the U.S. government’s recently announced Operation Warp Speed project.
- 07/14/2020
|
Veracity Capital LLC Purchases New Stake in Iqvia Holdings Inc (NYSE:IQV)
- Veracity Capital LLC purchased a new stake in Iqvia Holdings Inc (NYSE:IQV) during the 2nd quarter, Holdings Channel.com reports. The fund purchased 164,607 shares of the medical research company’s stock, valued at approximately $258,000. A number of other hedge funds and other institutional investors have also bought and sold shares of IQV. Stifel Financial Corp […]
- 07/14/2020
|
Carroll Financial Associates Inc. Increases Holdings in Iqvia Holdings Inc (NYSE:IQV)
- Carroll Financial Associates Inc. boosted its position in shares of Iqvia Holdings Inc (NYSE:IQV) by 90.3% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 236 shares of the medical research company’s stock after purchasing an additional 112 shares during the quarter. Carroll Financial […]
- 07/14/2020
|
IQVIA : to Announce Second-Quarter Results on July 22, 2020 | MarketScreener
|
IQVIA to Announce Second-Quarter Results on July 22, 2020
- IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), will announce its second-quarter financial results before the market opens on Wednesday, July 22, 2020. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.
- 07/08/2020
|
Were Hedge Funds Right About IQVIA Holdings, Inc. (IQV)?
- Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
- 07/08/2020
|
IQVIA : Collaborates with LMC Manna Research to Launch the Largest Clinical Investigation Site in Canada | MarketScreener
|
IQVIA Collaborates with LMC Manna Research to Launch the Largest Clinical Investigation Site in Canada
- IQVIA™ (NYSE: IQV) today announced its strategic alliance with LMC Manna Research, the largest network of fully owned and integrated clinical research sites in Canada, to launch IQVIA’s first Prime Site in Canada. This adds to our network of more than 980 Prime and Partner clinical sites globally, which are sites with special designation assuring pharmaceutical and biotech companies their clinical trials will take place in premier investigative research centers with recognized professionals and with infrastructure focused on innovation and research development for patients.
- 07/02/2020
|
Survey shows patients wait six times longer than EU neighbours for new drugs -
- Patients in some European countries are waiting up to six times longer for access to medicines than their neighbours, according to a survey by Europe’s pharma trade body.
- 07/02/2020
|
IQVIA Collaborates with LMC Manna Research to Launch the Largest Clinical Investigation Site in Canada
- IQVIA™ (NYSE: IQV) today announced its strategic alliance with LMC Manna Research, the largest network of fully owned and integrated clinical research
- 07/02/2020
|
What to expect from 'Modernizing the FDA's Data Strategy' meeting- STAT
- After being canceled because of Covid-19 pandemic, the FDA's public meeting to discuss data strategy is being held on Tuesday, June 30.
- 06/29/2020
|
Iqvia Holdings Inc (NYSE:IQV) Shares Bought by Schroder Investment Management Group
- Schroder Investment Management Group raised its position in Iqvia Holdings Inc (NYSE:IQV) by 427.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,685 shares of the medical research company’s stock after purchasing an additional 5,418 shares during the quarter. Schroder Investment Management Group’s […]
- 06/27/2020
|
Sanofi's Cost-Cutting Could Mean Big Job Losses | The Motley Fool
- The company's management is considering a restructuring that may eliminate many positions.
- 06/25/2020
|
Goldilocks and the Moat Concept
- Sometimes a moat is just as important to keep customers in as it is to keep competition out Continue reading...
- 06/23/2020
|
Huge Covid-19 infection survey set to be rolled out in Wales
- The data collected will allow the Office for National Statistics to build a 'reliable picture' of the infection rate in the country
- 06/23/2020
|
Millennials try video call-free days for digital detox
- As the working day stretches with people logging in from home, professionals are finding that they’re in front of their screens all day. They’re now consciously keeping tabs on screen time and observing digital detox routines in an effort to put a limit on the hours spent at work
- 06/22/2020
|
Iqvia Holdings Inc (NYSE:IQV) Stake Increased by Mackenzie Financial Corp
- Mackenzie Financial Corp increased its stake in Iqvia Holdings Inc (NYSE:IQV) by 23.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,448 shares of the medical research company’s stock after buying an additional 659 shares during the period. Mackenzie Financial Corp’s […]
- 06/21/2020
|
Trebia Acquisition Corp. : Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Units | MarketScreener
|
GENFIT : Voting Card - Shareholder meeting of June 30, 2020 | Zone bourse
|
Personalis : va participer au Congrès virtuel 2020 de l'European Association for Cancer Research (EACR) | Zone bourse
|
Trebia Acquisition Corp. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Units
- Trebia Acquisition Corp. (the “Company”) (NYSE: TREB.U) today announced the closing of its initial public offering of 51,750,000 units, which includes
- 06/19/2020
|
APG Asset Management N.V. Has $1.97 Million Position in Iqvia Holdings Inc (NYSE:IQV)
- APG Asset Management N.V. lowered its holdings in shares of Iqvia Holdings Inc (NYSE:IQV) by 48.2% during the first quarter, HoldingsChannel reports. The firm owned 15,400 shares of the medical research company’s stock after selling 14,303 shares during the quarter. APG Asset Management N.V.’s holdings in Iqvia were worth $1,973,000 as of its most recent […]
- 06/18/2020
|
Valneva : et Bavarian Nordic annoncent un partenariat pour le marketing et la distribution de leurs vaccins | Zone bourse
|
GENFIT : plus forte hausse du SBF 120 à la clôture du mercredi 17 juin 2020 | Zone bourse
|
GENFIT : plus forte hausse du SBF 120 à la mi-séance du mercredi 17 juin 2020 | Zone bourse
|
Valneva : Présentation Assemblée Générale 2020 | Zone bourse
|
EVOTEC : Deutsche Bank reiterates its Buy rating | MarketScreener
|
IQVIA UK Regulatory Announcement: IQVIA Announces Pricing of Offering of Senior Notes
- IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €711,000
- 06/11/2020
|
IQVIA Announces Pricing of Offering of Senior Notes
- IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €711,000,000 in...
- 06/10/2020
|
IQVIA : Announces Pricing of Offering of Senior Notes | MarketScreener
|
NANOBIOTIX : Curadigm valide sa technologie Nanoprimer dans les thérapies à base d'ARN | Zone bourse
|
Curadigm : annonce la publication, en collaboration avec le Langer Lab de résultats mettant en évidence la capacité de sa technologie Nanoprimer à augmenter l'efficacité des traitements à base d'ARN. | Zone bourse
|
Nanobiotix : LA FILIALE DE NANOBIOTIX CURADIGM VALIDE SA TECHNOLOGIE NOVATRICE NANOPRIMER DANS LES THERAPIES A BASE D'ARN | Zone bourse
|
Zacks: Brokerages Expect Iqvia Holdings Inc (NYSE:IQV) to Announce $1.05 EPS
- Equities analysts predict that Iqvia Holdings Inc (NYSE:IQV) will report earnings per share of $1.05 for the current quarter, according to Zacks. Seven analysts have made estimates for Iqvia’s earnings. The highest EPS estimate is $1.10 and the lowest is $1.03. Iqvia posted earnings of $1.53 per share during the same quarter last year, which […]
- 06/10/2020
|
AroCell publ : TK1 measurements in serum correlate with the treatment response in breast cancer patients | MarketScreener
|
IQVIA Inc. -- Moody's assigns Ba3 rating to IQVIA's new senior unsecured notes
- Moody's Investors Service ("Moody's") assigned a Ba3 rating to the proposed senior unsecured notes of IQVIA Inc. ("IQVIA"). There are no changes to IQVIA's existing ratings, including the Ba2 Corporate Family Rating, Ba2-PD Probability of Default Rating, and SGL-1 Speculative Grade Liquidity Rating. Use of proceeds from the notes offering will include refinancing existing unsecured notes and a partial repayment of revolver borrowings.
- 06/09/2020
|
IQVIA UK Regulatory Announcement: IQVIA Announces Offering of Senior Notes
- IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), intends to raise $800,000,000
- 06/09/2020
|
IQVIA : Q² Solutions, an IQVIA and Quest Diagnostics Joint Venture, Improves Oncology's Standard of Care with Genomics Technology Collaboration | MarketScreener
|
Q2 Solutions, an IQVIA and Quest Diagnostics Joint Venture, Improves Oncology’s Standard of Care with Genomics Technology Collaboration
- Q2 Solutions, a leading clinical trial laboratory services organization resulting from an IQVIA and Quest Diagnostics joint venture, today announced its partnership with Thermo Fisher Scientific to use the Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform, to deliver clinical trial lab results economically with unprecedented speed.
- 06/03/2020
|
Global Pharmaceutical Glass Packaging Market (2020 to 2025) - Growth, Trends and Forecast - ResearchAndMarkets.com
|
Forget IQVIA, Veeva Systems Is a Better Growth Stock
- Here’s why Veeva Systems is the better choice for investors looking for exposure to companies performing clinical trial analytics.
- 06/02/2020
|
Here's Why You Should Hold IQVIA Holdings (IQV) Stock Now
- Solid technological suite and growth opportunities from emerging markets are positives for IQVIA Holdings (IQV). However, higher interest expense, seasonality and foreign exchange rate risks persist.
- 06/01/2020
|
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q1 2020 Update
- Glenview Capital Management’s 13F portfolio value decreased around two-thirds from $11.42B to $3.68B this quarter. The number of positions decreased from 50 to
- 06/01/2020
|
Lone Pine Capital Exits Salesforce, Union Pacific
- Firm's largest sales of the 1st quarter Continue reading...
- 05/28/2020
|
Why Is IQVIA (IQV) Up 2.6% Since Last Earnings Report?
- IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 05/28/2020
|
Larry Robbins' Firm Chips Away at Top Holdings During the 1st Quarter
- Glenview’s sells include Cigna and HCA Continue reading...
- 05/27/2020
|
Hedge Funds Kept Selling IQVIA Holdings, Inc. (IQV) During The Crash
- The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]
- 05/26/2020
|
Anti-anxiety medication prescriptions have spiked 34% during the coronavirus pandemic
- Americans are also filling more prescriptions for antidepressants and anti-insomnia drugs
- 05/26/2020
|
More People Are Taking Drugs for Anxiety and Insomnia, and Doctors Are Worried
- As coronavirus health concerns, social isolation and job-loss stress take a toll, people turn to medications; “It can very quickly become a habit.”
- 05/25/2020
|
IQVIA Launches the First Solution to Address the Unique Business and Compliance Needs of Healthcare Professionals as Part of Its OCE Suite
- IQVIA™ (NYSE: IQV) today announced the launch of HCP/O Engagement Management, the industry’s first end-to-end, orchestrated healthcare professional/organization (HCP/O) solution that enables the planning, management, contracting, and payment of HCP/Os globally.
- 05/21/2020
|
IQVIA Launches the First Solution to Address the Unique Business and Compliance Needs of Healthcare Professionals as Part of Its OCE Suite
- IQVIA™ (NYSE: IQV) today announced the launch of HCP/O Engagement Management, the industry’s first end-to-end, orchestrated healthcare professional/or
- 05/21/2020
|
IQVIA Collaborates with Australian Medical Research Institute on COVID-19 Study to Support Frontline Healthcare Workers
- IQVIA™ (NYSE: IQV) today announced that the Walter and Eliza Hall Institute of Medical Research, a leading biomedical research organization in Australia, has selected IQVIA to manage COVID SHIELD, a Phase II/III randomized, double-blinded clinical study of preventive care for frontline healthcare workers fighting the COVID-19 pandemic.
- 05/20/2020
|
Trump attacks study, defends using malaria drug for COVID-19
- President Donald Trump attacked the validity of a study of veterans that raised alarms about the malaria drug he actively promotes as a treatment for the coronavirus
- 05/20/2020
|
IQVIA Collaborates with Australian Medical Research Institute on COVID-19 Study to Support Frontline Healthcare Workers
- IQVIA™ (NYSE: IQV) today announced that the Walter and Eliza Hall Institute of Medical Research, a leading biomedical research organization in Austral
- 05/20/2020
|
Veeva: Strength In An Unsteady Environment (NYSE:VEEV)
- Veeva has exceeded expectations due to strong revenue growth in the recent quarter. Competition has been aggressive but Veeva appears to be winning. The company
- 05/19/2020
|
From Hollywood A-listers to a dragon - the Berkshire Rich List
- There is some serious money in the county
- 05/19/2020
|
AroCell publ : TK1 measurements in serum correlate with the treatment response in breast cancer patients | MarketScreener
|
Despite risks, Trump says he's taking hydroxychloroquine
- President Donald Trump is drawing criticism from Democratic leaders after saying he has been taking the malaria drug he has touted as a treatment for the coronavirus
- 05/19/2020
|
Trump says he’s taking zinc, hydroxychloroquine to protect himself against coronavirus
- President Donald Trump said on Monday that he is consuming zinc and hydroxychloroquine to protect himself against the new coronavirus. The President is taking the malarial drug despite warnings from his own government that it should only be administered for COVID-19 in a hospital or research setting due to potentially fatal side effects.
- 05/19/2020
|
Trump says he's taking malaria drug to protect against virus
- WASHINGTON (AP) - President Donald Trump said Monday that he is taking a malaria drug to protect against the new coronavirus, despite warnings from his own government that it should only be administered for COVID-19 in a hospital or research setting due to potentially fatal side effects.
Trump told reporters he has been taking the drug, hydroxychloroquine, and a zinc supplement daily "for about a week and a half now." Trump spent weeks pushing the drug as a potential cure or prophylaxis for COVID-19 against the cautionary advice of many of his administration's top medical professionals. The drug has the potential to cause significant side effects in some patients and has not been shown to combat the new coronavirus.
Trump said his doctor did not recommend the drug to him, but he requested it from the White House physician.
"I started taking it, because I think it's good," Trump said. "I've heard a lot of good stories."
The Food and Drug Administration warned health professionals last month that the drug should not be used to treat COVID-19 outside of hospital or research settings, due to sometimes fatal side effects. Regulators issued the alert for the drug, which can also be used to treat lupus and arthritis, after receiving reports of heart rhythm problems, including deaths, from poison control centers and other health providers.
Trump dismissed reports of side effects, saying, "All I can tell you is, so far I seem to be OK."
At least two White House staffers tested positive for COVID-19 earlier this month, sparking concerns about the steps taken by the administration to protect the president and sending Vice President Mike Pence and other officials into varying forms of self-isolation.
The White House has since mandated that those in the West Wing...
- 05/18/2020
|
Trump says he’s taking malaria drug in case he gets virus
- Trump told reporters he has been taking the drug, hydroxychloroquine, and a zinc supplement daily ‘for about a week and a half now'
- 05/18/2020
|
Trump says he's taking malaria drug to protect against virus
- WASHINGTON (AP) - President Donald Trump said Monday that he is taking a malaria drug to protect against the coronavirus, despite warnings from his own...
- 05/18/2020
|
GENFIT : Information financière du premier trimestre 2020 | Zone bourse
|
AroCell AB (publ) : Interim Report January 1st to March 31st, 2020 | MarketScreener
|
Peloton, Morgan Stanley, and 10 More Stocks for the Covid-19 Era
- Goldman Sachs has identified a dozen stocks that the bank’s analysts are confident will report earnings over the next year that are better than the Street expects.
- 05/14/2020
|
Mail-Order Drug Delivery Rises During Coronavirus Lockdowns | MarketScreener
|
Neos Therapeutics. Inc. (NEOS) CEO Jerry McLaughlin on Q1 2020 Results - Earnings Call Transcript
- Neos Therapeutics, Inc. (NASDAQ:NEOS) Q1 2020 Earnings Conference Call May 11, 2020, 05:00 PM ET Company Participants Richard Eisenstadt - Chief Financial Offic
- 05/12/2020
|
About 136,000 people in England currently infected with COVID-19 -study
- Around 136,000 people in England are currently infected with COVID-19, according to early results from the first large-scale study in Britain into the spread of the disease.
- 05/11/2020
|
Envestnet's (ENV) Q1 Earnings Beat Estimates, Improve Y/Y
- Envestnet's (ENV) first- quarter 2020 earnings and revenues increase year over year.
- 05/11/2020
|
Beware of bloated executive pay
- Companies that fail their "say-on-pay" votes tend to underperform.
- 05/08/2020
|
Gartner (IT) Surpasses Q1 Earnings Estimates, Cuts View
- Gartner (IT) first-quarter 2020 earnings and revenues increase year over year.
- 05/07/2020
|
OPKO Health, Inc. (OPK) CEO Dr. Phillip Frost on Q1 2020 Results - Earnings Call Transcript
- Call end: 17:12 OPKO Health, Inc. (NASDAQ:OPK) Q1 2020 Earnings Conference Call May 6, 2020 4:30 PM ET Company Participants Yvonne Briggs - LHA IR Phillip Frost
- 05/07/2020
|
Life Science Analytics Software Market is Estimated to Reach $16.04 Billion by 2027: AMR
- Portland, OR, May 06, 2020 (GLOBE NEWSWIRE via COMTEX) --
Portland, OR, May 06, 2020 (GLOBE NEWSWIRE) -- Allied Market Research recently published a report,...
- 05/06/2020
|
UK coronavirus live: draft rules on post-lockdown workplaces leaked
- BBC reports it has seen regulations which include staggered shift times and reduced hot-desking
- 05/04/2020
|
Myst Therapeutics Appoints George Smith as Vice President of Business Operations
- Myst Therapeutics (Myst), a preclinical stage biotechnology company focused on developing selected TIL-based autologous T cell (PuriT™) therapy produc
- 05/04/2020
|
Results: IQVIA Holdings Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
- It's been a pretty great week for IQVIA Holdings Inc. (NYSE:IQV) shareholders, with its shares surging 11% to US$143...
- 05/01/2020
|
IQVIA Holdings Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
- It's been a pretty great week for IQVIA Holdings Inc. (NYSE:IQV) shareholders, with its shares surging 11% to US$143...
- 05/01/2020
|
4 Service Givers to Beat on Q1 Earnings Amid Coronavirus Crisis
- This season will not reflect the full impact of the COVID-19-related setbacks as the outbreak started affecting businesses from the second half of March.
- 05/01/2020
|
Iqvia (NYSE:IQV) Stock Price Up 5.3% Following Earnings Beat
- Shares of Iqvia Holdings Inc (NYSE:IQV) rose 5.3% on Wednesday after the company announced better than expected quarterly earnings. The company traded as high as $143.45 and last traded at $143.10, approximately 1,428,149 shares were traded during trading. A decline of 22% from the average daily volume of 1,838,108 shares. The stock had previously closed […]
- 05/01/2020
|
Amgen Inc (NASDAQ: AMGN) Q1 2020 Earnings Call Transcript | AlphaStreet
- Final earnings conference call transcript of Amgen Inc - AMGN stock
- 05/01/2020
|
IQVIA Joins UK Government Collaboration to Provide Single Research Platform to Speed Development of New COVID-19 Treatments
- IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry, has joined the ACCORD-2 collaboration, which will fast-track development of new treatments for COVID-19. IQVIA will provide a single research platform across the United Kingdom to facilitate multiple clinical trials regardless of sponsor. This strategic alliance will examine the effectiveness of repurposed medicines, potential new drugs, and unlicensed therapies for treating COVID-19 patients.
- 04/29/2020
|
IQVIA Holdings Inc. (IQV) Q1 2020 Earnings Call Transcript
- With me on the call today are Ari Bousbib, Chairman and Chief Executive Officer; Michael McDonnell, Executive Vice President and Chief Financial Officer; Eric Sherbet, Executive Vice President and General Counsel; Nick Childs, Senior Vice President, Financial Planning and Analysis; and Jen Halchak, Senior Director, Investor Relations. Today, we will be referencing a presentation that will be visible during this call for those of you on our webcast.
- 04/28/2020
|
Iqvia braces for greatest impact from pandemic in Q2, but sees return to normal by 2021
- Iqvia has reported its first quarter results for 2020.
- 04/28/2020
|
IQVIA Holdings, Inc. (IQV) CEO Ari Bousbib on Q1 2020 Results - Earnings Call Transcript
- IQVIA Holdings, Inc. (NYSE:IQV) Q1 2020 Earnings Conference Call April 28, 2020, 09:00 ET Company Participants Andrew Markwick - VP, IR Ari Bousbib - Chairman,
- 04/28/2020
|
IQVIA Holdings: Q1 Earnings Insights
- Shares of IQVIA Holdings (NYSE:IQV) rose 1.3% after the company reported Q1 results.Quarterly Results Earnings per share decreased 1.96% over the past year to $1.50, which beat the estimate of $1.48.Revenue of $2,754,000,000 up by 2.61% from the same period last year, which beat the estimate of $2,720,000,000.Guidance Q2 EPS expected to be between $1.00 and $1.14.Q2 revenue expected to be between $2,365,000,000 and $2,440,000,000.Conference Call Details Date: Apr 28, 2020View more earnings on IQVTime: 10:05 AM ETWebcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer;=https%3A%2F%2Fir.iqvia.com%2Fevents-and-presentations%2Fdefault.aspx&eventid;=2160215&sessionid;=1&key;=F113A19EF878954541CB973E5F79F55A®Tag;=&sourcepage;=registerTechnicals 52-week high: $169.14Company's 52-week low was at $81.79Price action over last quarter: down 19.23%Company Overview IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The CRO segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The legacy IMS business provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers.See more from Benzinga * Sirius XM Holdings: Q1 Earnings Insights * TE Connectivity: Q2 Earnings Insights * Recap: Cummins Q1 Earnings(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 04/28/2020
|
IQVIA (IQV) Beats on Q1 Earnings, Revenues, Lowers '20 View
- IQVIA's (IQV) first-quarter 2020 revenues increase year over year while earnings decline.
- 04/28/2020
|
IQVIA (IQV) Beats on Q1 Earnings, Revenues, Lowers '20 View
- IQVIA's (IQV) first-quarter 2020 revenues increase year over year while earnings decline.
- 04/28/2020
|
Where to Find Stock Gems in the Stock Market Now
- Finding oversold stocks in a crisis-driven market isn’t easy. Arm yourself with these criteria.
- 04/28/2020
|
IQVIA Holdings (IQV) Q1 Earnings and Revenues Beat Estimates
- IQVIA (IQV) delivered earnings and revenue surprises of 1.35% and 1.38%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 04/28/2020
|
IQVIA Holdings (IQV) Q1 Earnings and Revenues Beat Estimates
- IQVIA (IQV) delivered earnings and revenue surprises of 1.35% and 1.38%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 04/28/2020
|
IQVIA lowers guidance due to COVID-19 impact
- IQVIA (IQV) Q1 results:Revenues: $2,754M (+2.6%).Net Income: $82M (+41.4%); EPS: $0.42 (+44.8%); non-GAAP Net Income: $294M (-4.9%); non-GAAP EPS: $1.50 (-2.0%); non-GAAP EBITDA: $562M (-4.3%).CF Ops:
- 04/28/2020
|
BRIEF-Iqvia Reports Q1 Adjusted Earnings Per Share Of $1.50
- IQVIA Holdings Inc:
- 04/28/2020
|
IQVIA: 1Q Earnings Snapshot
- DURHAM, N.C. (AP) _ IQVIA Holdings Inc. (IQV) on Tuesday reported first-quarter earnings of $82 million.
The Durham, North Carolina-based company said it had net income of 42 cents per share. Earnings, adjusted for one-time gains and costs, were $1.5
- 04/28/2020
|
Hartford Investment Management Co. Purchases 675 Shares of Iqvia Holdings Inc (NYSE:IQV)
- Hartford Investment Management Co. raised its position in Iqvia Holdings Inc (NYSE:IQV) by 3.5% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,092 shares of the medical research company’s stock after acquiring an additional 675 shares during the quarter. Hartford Investment Management Co.’s holdings […]
- 04/28/2020
|
IQVIA Reports First-Quarter 2020 Results; Issues Second-Quarter 2020 Guidance and Updates Full-Year 2020 Guidance
- IQVIA Reports First-Quarter 2020 Results; Issues Second-Quarter 2020 Guidance and Updates Full-Year 2020 Guidance
- 04/28/2020
|
Iqvia Holdings Inc (NYSE:IQV) Shares Sold by Artemis Investment Management LLP
- Artemis Investment Management LLP cut its stake in shares of Iqvia Holdings Inc (NYSE:IQV) by 32.4% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 91,113 shares of the medical research company’s stock after selling 43,697 shares during the period. Artemis Investment Management LLP’s holdings […]
- 04/28/2020
|
IQVIA Q1 2020 Earnings Preview
- IQVIA (NYSE:IQV) is scheduled to announce Q1 earnings results on Tuesday, April 28th, before market open.The consensus EPS Estimate is $1.50 (-2.0% Y/Y) and the consensus Revenue Estimate is $2.74B (+
- 04/27/2020
|
Should You Buy IQVIA Holdings (IQV) Ahead of Earnings?
- IQVIA Holdings (IQV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 04/27/2020
|
Should You Buy IQVIA Holdings (IQV) Ahead of Earnings?
- IQVIA Holdings (IQV) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 04/27/2020
|
Eli Lilly Q1 Earnings Call Key Takeaways
- We highlight main points from LLY Q1 conference call and summarize key takeaways for investors. Q1 was strong due to COVID-19 boost, but the company expects nea
- 04/27/2020
|
Business Services Apr 28 Earnings Rooster: SPGI, IQV & More
- Here's a sneak peek of how four business service stocks are placed prior to the respective earnings releases on Apr 28.
- 04/27/2020
|
Business Services Apr 28 Earnings Rooster: SPGI, IQV & More
- Here's a sneak peek of how four business service stocks are placed prior to the respective earnings releases on Apr 28.
- 04/27/2020
|
Iqvia Holdings Inc (NYSE:IQV) Shares Purchased by Envestnet Asset Management Inc.
- Envestnet Asset Management Inc. boosted its holdings in Iqvia Holdings Inc (NYSE:IQV) by 22.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 299,627 shares of the medical research company’s stock after purchasing an additional 55,860 shares during the quarter. Envestnet Asset Management Inc. owned […]
- 04/27/2020
|
Livforsakringsbolaget Skandia Omsesidigt Grows Position in Iqvia Holdings Inc (NYSE:IQV)
- Livforsakringsbolaget Skandia Omsesidigt grew its stake in Iqvia Holdings Inc (NYSE:IQV) by 30.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,733 shares of the medical research company’s stock after purchasing an additional 400 shares during the period. Livforsakringsbolaget Skandia […]
- 04/25/2020
|
IQVIA (IQV) to Report Q1 Earnings: What's in the Cards?
- IQVIA's (IQV) first-quarter 2020 revenues are likely to have benefited from strength across Research & Development Solutions, Technology & Analytics Solutions and Contract Sales & Medical Solutions.
- 04/24/2020
|
IQVIA (IQV) to Report Q1 Earnings: What's in the Cards?
- IQVIA's (IQV) first-quarter 2020 revenues are likely to have benefited from strength across Research & Development Solutions, Technology & Analytics Solutions and Contract Sales & Medical Solutions.
- 04/24/2020
|
Unlocking health data to improve oncology outcomes -
- As NICE makes increasing use of real-world evidence and innovative approaches, including DATA-CAN, are developed, there is an opportunity to improve the patient experience
- 04/24/2020
|
Were Hedge Funds Right About TransDigm Group Incorporated (TDG)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/23/2020
|
UK coronavirus study to test 300,000 people for infection and immunity
- The UK is to test 300,000 people over the next 12 months to discover levels of coronavirus infection and immunity in the population. Twenty thousand households are already being contacted in the first wave of the study, which aims to cover a representative sample of people living in the UK by geography and age. “Understanding more about the rate of Covid-19 infection in the general population, and the longer-term prevalence of antibodies, is a vital part of our ongoing response to this virus,” Matt Hancock, health secretary, said when announcing the study on Thursday morning.
- 04/23/2020
|
UK to test prevalence of COVID-19 in general population
- Britain's government plans to test a sample of 20,000 English households for COVID-19 in the coming weeks to try to establish how far the disease has spread across the country.
- 04/22/2020
|
Were Hedge Funds Right About IQVIA Holdings, Inc. (IQV)?
- Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- 04/22/2020
|
Iqvia Holdings Inc (NYSE:IQV) Stock Position Lifted by First Hawaiian Bank
- First Hawaiian Bank grew its position in shares of Iqvia Holdings Inc (NYSE:IQV) by 10.0% during the first quarter, HoldingsChannel reports. The institutional investor owned 14,068 shares of the medical research company’s stock after buying an additional 1,278 shares during the quarter. First Hawaiian Bank’s holdings in Iqvia were worth $1,517,000 as of its most […]
- 04/22/2020
|
How Should Investors React To IQVIA Holdings Inc.’s (NYSE:IQV) CEO Pay?
- In 2016, Ari Bousbib was appointed CEO of IQVIA Holdings Inc. (NYSE:IQV). First, this article will compare CEO...
- 04/21/2020
|
People are filling more prescriptions by mail amid coronavirus crisis
- Many also stocked up on medications, which often come in 90-day supplies.
- 04/21/2020
|
Iqvia (IQV) to Release Quarterly Earnings on Tuesday
- Iqvia (NYSE:IQV) is set to release its earnings data before the market opens on Tuesday, April 28th. Analysts expect Iqvia to post earnings of $1.36 per share for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link. Iqvia (NYSE:IQV) last announced its quarterly earnings results […]
- 04/21/2020
|
RPT-Drug trial specialists see coronavirus-fueled spike in demand for virtual services
- Clinical trial service providers report a spike in demand for virtual trials as pharmaceutical companies try to prevent the coronavirus outbreak from derailing their drug rollouts.
- 04/20/2020
|
Allred Capital Management LLC Buys Shares of 922 Iqvia Holdings Inc (NYSE:IQV)
- Allred Capital Management LLC bought a new stake in shares of Iqvia Holdings Inc (NYSE:IQV) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 922 shares of the medical research company’s stock, valued at approximately $99,000. Other large investors have […]
- 04/19/2020
|
Macquarie Group Ltd. Sells 39,227 Shares of Iqvia Holdings Inc (NYSE:IQV)
- Macquarie Group Ltd. cut its position in shares of Iqvia Holdings Inc (NYSE:IQV) by 2.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,395,606 shares of the medical research company’s stock after selling 39,227 shares during the period. Macquarie Group Ltd. […]
- 04/18/2020
|
Iqvia (NYSE:IQV) vs. PPD (NYSE:PPD) Financial Analysis
- PPD (NASDAQ:PPD) and Iqvia (NYSE:IQV) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations. Profitability This table compares PPD and Iqvia’s net margins, return on equity and return on assets. Net Margins […]
- 04/18/2020
|
IQVIA Holdings: No Premium Amid Uncertainty
- The COVID-19 pandemic severely impacts IQVIA’s contract research function even though the company’s well-diversified top line, unlike that of peers, lessens the
- 04/17/2020
|
Drug trial specialists see coronavirus-fueled spike in demand for virtual services
- Clinical trial service providers report a spike in demand for virtual trials as pharmaceutical companies try to prevent the coronavirus outbreak from derailing their drug rollouts.
- 04/17/2020
|
Iqvia Holdings Inc (NYSE:IQV) Shares Sold by Brookstone Capital Management
- Brookstone Capital Management reduced its stake in shares of Iqvia Holdings Inc (NYSE:IQV) by 7.3% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,749 shares of the medical research company’s stock after selling 376 shares during the quarter. Brookstone Capital Management’s holdings […]
- 04/16/2020
|
Chesley Taft & Associates LLC Boosts Position in Iqvia Holdings Inc (NYSE:IQV)
- Chesley Taft & Associates LLC increased its holdings in shares of Iqvia Holdings Inc (NYSE:IQV) by 7.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 6,470 shares of the medical research company’s stock after purchasing an additional 440 shares […]
- 04/16/2020
|
Iqvia Holdings Inc (NYSE:IQV) Shares Sold by Artemis Investment Management LLP
- Artemis Investment Management LLP decreased its holdings in shares of Iqvia Holdings Inc (NYSE:IQV) by 32.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 91,113 shares of the medical research company’s stock after selling 43,697 shares during the quarter. […]
- 04/15/2020
|
AMF Pensionsforsakring AB Sells 89,398 Shares of Iqvia Holdings Inc (NYSE:IQV)
- AMF Pensionsforsakring AB reduced its holdings in Iqvia Holdings Inc (NYSE:IQV) by 47.2% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 100,095 shares of the medical research company’s stock after selling 89,398 shares during the quarter. AMF Pensionsforsakring AB owned about […]
- 04/15/2020
|
Iqvia (NYSE:IQV) PT Lowered to $155.00 at Citigroup
- Iqvia (NYSE:IQV) had its price objective cut by Citigroup from $195.00 to $155.00 in a research note issued to investors on Thursday, BenzingaRatingsTable reports. They currently have a buy rating on the medical research company’s stock. Several other equities analysts also recently commented on IQV. Barclays dropped their price objective on Iqvia from $192.00 to […]
- 04/13/2020
|
Iqvia Holdings Inc (NYSE:IQV) Forecasted to Post Q2 2020 Earnings of $1.10 Per Share
- Iqvia Holdings Inc (NYSE:IQV) – Equities research analysts at Piper Sandler cut their Q2 2020 earnings per share (EPS) estimates for shares of Iqvia in a report released on Tuesday, April 7th. Piper Sandler analyst S. Wieland now expects that the medical research company will post earnings of $1.10 per share for the quarter, down […]
- 04/11/2020
|
IBM Retirement Fund Increases Stock Holdings in Iqvia Holdings Inc (NYSE:IQV)
- IBM Retirement Fund boosted its position in shares of Iqvia Holdings Inc (NYSE:IQV) by 59.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,172 shares of the medical research company’s stock after acquiring an additional 1,552 shares during the quarter. IBM Retirement Fund’s […]
- 04/10/2020
|
